fashion -WSS

fashion

author：hotspot 2025-09-30 23:11:00 - browse：62

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic.

New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly. So far this year, there have been 1,384 VC deals struck in the field, the lowest figure since 2013. For comparison, there were roughly 2,122 financing deals made last year.

If dealmaking remains consistent for the rest of the year, it would put this year on par with the number of deals made in 2017.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： FDA weighs limits of animal data in assessing artificial wombs

leisure time

focus

WSS

Information blocking fines are now fair game in health care

10 million people disenrolled from Medicaid over past six months

Chamber of Commerce, DOJ clash in court over drug prices

The unintended consequences of overturning Roe v. Wade

Victims of gun violence feel impacts long after bullet wound

Sanofi CEO defends move to abandon profit guidance, boost research

knowledge

fashion

focus

At least 13 dead in Texas as scorching temps continue

House panel takes first step toward fixing drug shortages

Psychedelics group wrestles with new pharma identity

The struggle to figure out which patients 'deserve' Wegovy

Peter Hotez and the public health issue of online harassment

UCSF medical school apologizes for unethical prisoner experiments

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Fed up with FDA, ALS advocates consider a take

George Santos makes 1st court appearance after pleading not guilty to 13 counts

More doctors should go into startup world

Wikipedia

Neurocrine congenital adrenal hyperplasia trial succeeds

How the messy conversation about Dolly changed bioethics

Free speech concerns arise in wake of journal editor Eisen's firing

Eli Lilly CEO gives to Mike Pence presidential super PAC

Extreme heat events are a public health emergency

STAT Executive Editor Rick Berke on STAT's 8th birthday

leisure time

focus

focus

explore